Quick Answer
RHYTHM PHARMACEUTICALS, INC. reported Total Revenue of $189.76 million for fiscal year 2025.
RHYTHM PHARMACEUTICALS, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $189.76M | +45.8% |
| 2024 | $130.13M | +68.1% |
| 2023 | $77.43M | +227.6% |
| 2022 | $23.64M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $51.30M | +54.3% | +5.8% |
| June 30, 2025 | $48.50M | +66.8% | +48.3% |
| March 31, 2025 | $32.70M | +25.9% | -1.6% |
| September 30, 2024 | $33.25M | +47.8% | +14.4% |
| June 30, 2024 | $29.08M | — | +12.0% |
| March 31, 2024 | $25.97M | — | +15.4% |
| September 30, 2023 | $22.50M | — | — |
- RHYTHM PHARMACEUTICALS, INC. showed an increase of +45.8% in Total Revenue compared to the prior fiscal year.
- Over the 2022–2025 period, RHYTHM PHARMACEUTICALS, INC.’s total revenue has grown by 702.8% (from $23.64 million to $189.76 million).
- The most recent figure is from RHYTHM PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: